volume 28, issue 3, P18-24 2007
DOI: 10.2500/aap.2007.28.2993
View full text
|
Sign up to set email alerts
|
Share

Abstract: Intranasal corticosteroids (INCSs) provide safe and effective treatment of allergic rhinitis (AR). Currently available INCSs differ in terms of the components included in each formulation that may influence efficacy, tolerability, and patient preference for treatment. Patient preference for a specific INCS is largely attributable to the sensory attributes that are dependent on characteristics of the formulation. Preservatives and additives can irritate and dry the mucosal membranes, or they can confer an unple…

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

0
6
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals